StonvexLoading…
StonvexStonvexStonvexCore line items from KTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $613.32M | $3.15B | $2.13B | $1.28B |
Operating Income | $90.11M | $336.81M | $215.69M | $151.84M |
Net Income | $92.44M | $227.45M | $153.69M | $73.87M |
EPS (Diluted) | $1.65 | $4.05 | $2.74 | $2.08 |
Total Assets | $2.65B | $2.58B | $2.86B | $2.72B |
Total Liabilities | $2.03B | $2.02B | $2.33B | $2.22B |
Cash & Equivalents | $56.41M | $77.22M | $82.43M | $107.48M |
Free Cash Flow OCF − CapEx | $40.30M | $434.76M | $153.00M | $97.24M |
Shares Outstanding | 55.16M | 55.24M | 55.58M | 55.57M |